Pooled 10-donor, male human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
FlashGelTM Recovery Cassettes, 1.2% 8+1 well double-tier, 9 pack
Fast and convenient DNA recovery at the bench
Separation: 50 bp - 4 kb
Cryopreserved ampule of Rat Neonatal Cardiomyocytes containing ≥4 million cells
Cryopreserved ampule of Human Peripheral Blood CD14+ Monocytes, positive selection, containing ≥10 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Cryopreserved ampule of Human Peripheral Blood CD14+ Monocytes, positive selection, containing ≥20 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
-
References - X-Vivo™Overview of relevant references
-
TechSheet - X-VIVO™ Media SystemsInstructions for how to use the X-VIVO™ Media Series
-
TheraPEAK® X-VIVO® Hematopoietic Cell Culture MediumSerum-free, GMP produced medium for cell therapy applications
-
Primary Normal Human Cells and MediaIn Vivo Relevance. In Vitro Results. Updated and revised cell content.
-
Formulation - Leibovitz Medium (L-15)Components present in L-15 (12-700).
-
Formulation - Leibovitz Modified Medium (L-15)Composition of L-15 (12-669)
-
A Non-Viral Method for Modifying and Expanding Primary T CellsLearn how Lonza’s Cocoon® Platform, 4D-Nucleofector® LV Unit and X-VIVO® 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.
-
A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies]Manuscript published in Applied In Vitro Toxicology journal describes improvement of CYP450 phenotype of primary cryopreserved hepatocytes using Quasi Vivo® System
-
Instructions for Use - TheraPEAK® T-VIVO® Cell Culture MediumInstructions for how to use the TheraPEAK® T-VIVO® Cell Culture Media Series
-
Serum-free Media FFM Part Codes2019 change of all RUO Media to FFM production overview of RUO and new FFM part codes (X-VIVO not included)